Mikkel Kristiansen is the CEO of VentriJect, a Danish healthtech company focused on driving workforce longevity by solving the key scalability challenge in corporate health.
Drawing on over a decade of extensive international experience and leadership in medical technology commercialization, Mikkel specializes in translating clinical-validated technologies into practical, scalable health solutions.
Under his leadership, VentriJect developed the innovative, non-exercise solution, Seismofit, that assesses VO2max—the strongest indicator of health—in under three minutes. His mission is to move corporate health beyond subjective metrics, empowering employers with the critical, objective data needed to manage human capital and ensure a resilient, high-performing global workforce.